DEF: American Healthcare REIT Sets Stage for 2025 with Annual Stockholder Meeting and Equity Plan Approval

Sentiment:

Proxy Statement


American Healthcare REIT is holding its 2025 Annual Meeting of Stockholders on June 25, 2025, to vote on key proposals including director elections, auditor ratification, executive compensation, and a new manager equity plan.

Better than expectedThe company achieved a 17.7% Same-Store NOI growth for the twelve months ended December 31, 2024.The company achieved a 4.2x improvement in our Net Debt-to-Adjusted EBITDA from 8.5x as of December 31, 2023 to 4.3x as of December 31, 2024.

Summary

  • American Healthcare REIT will hold its 2025 Annual Meeting of Stockholders on June 25, 2025, in Irvine, California.
  • Stockholders will vote on the election of nine directors, ratification of Deloitte & Touche as the independent accounting firm, approval of executive compensation, and approval of the 2025 Manager Equity Plan.
  • The board recommends voting 'FOR' all director nominees, ratifying Deloitte & Touche, approving executive compensation, and approving the 2025 Manager Equity Plan.
  • The company's outstanding common stock as of the record date, March 27, 2025, was 158,691,084 shares.
  • The 2025 Manager Equity Plan proposes to allocate 1,000,000 shares for equity-based incentives to third-party managers.
  • The company details its corporate governance practices, including director independence, committee structures, and risk oversight.
  • Executive compensation includes base salary, short-term incentives (cash bonuses), and long-term incentives (equity-based compensation).
  • The company achieved a 17.7% Same-Store NOI growth for the twelve months ended December 31, 2024.
  • The company completed three public offerings in 2024, raising $1.36 billion in gross proceeds.
  • The company acquired the remaining minority interest in Trilogy Holdings for $258.0 million.
  • The company paid down $176.1 million of variable-rate mortgage loans and $739.0 million on variable-rate lines of credit in 2024.
  • The company disposed of approximately four OM buildings, eight triple-net leased properties, one ISHC facility and one SHOP, generating approximately $155.5 million in gross proceeds.

Sentiment

Score: 7

Explanation: The document presents a balanced view with positive financial achievements offset by a net loss. The focus on corporate governance and future growth initiatives contributes to a moderately positive outlook.

Positives

  • The company achieved a 17.7% Same-Store NOI growth for the twelve months ended December 31, 2024.
  • The company completed three public offerings in 2024, raising $1.36 billion in gross proceeds.
  • The company acquired the remaining minority interest in Trilogy Holdings for $258.0 million.
  • The company paid down $176.1 million of variable-rate mortgage loans and $739.0 million on variable-rate lines of credit in 2024.
  • The company disposed of approximately four OM buildings, eight triple-net leased properties, one ISHC facility and one SHOP, generating approximately $155.5 million in gross proceeds.
  • The company achieved a 4.2x improvement in our Net Debt-to-Adjusted EBITDA from 8.5x as of December 31, 2023 to 4.3x as of December 31, 2024.

Negatives

  • The company reported a GAAP net loss attributable to controlling interest of $37.8 million for the twelve months ended December 31, 2024.

Risks

  • The document mentions cybersecurity risks and the need for ongoing monitoring and control measures.
  • The document mentions interest rate volatility impacting the real estate markets.

Future Outlook

The company aims to build a more resilient future and create long-term value for its stakeholders through its corporate responsibility program.

Management Comments

  • Jeffrey T. Hanson, Non-Executive Chairman of the Board of Directors, expresses gratitude for stockholders' continued support.
  • Management will provide an update on the company's portfolio and performance at the 2025 Annual Meeting of Stockholders.

Industry Context

The document references several other healthcare REITs as part of its peer group for executive compensation benchmarking, indicating awareness of industry standards and competitive practices.

Comparison to Industry Standards

  • The document benchmarks executive compensation against a peer group of publicly traded REITs, including Brandywine Realty Trust, CareTrust REIT, Global Medical REIT Inc., Healthcare Realty Trust Incorporated, Highwoods Properties, Inc., LTC Properties, Inc., National Health Investors, Inc., Peakstone Realty Trust, Physicians Realty Trust, Piedmont Office Realty Trust, Inc., Retail Opportunity Investments Corp., Sabra Health Care REIT, Inc., Sila Realty Trust, Inc., and SmartStop Self Storage REIT, Inc..
  • The document compares the company's performance to that of other healthcare REITs, including CareTrust REIT, Healthcare Realty Trust Incorporated, LTC Properties Inc., National Health Investors, Inc., Healthpeak Properties, Inc., Sabra Health Care REIT, Inc., Omega Healthcare Investors, Inc., Ventas, Inc. and Welltower, Inc.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board CompositionThe Board of Directors currently consists of nine directors, a majority of whom are independent.N/AEnsures independent oversight and management accountability.
Committee StructureThe Board has established an Audit Committee, a Compensation Committee, and a Nominating and Corporate Governance Committee, all comprised entirely of independent directors.N/AProvides independent oversight of key areas such as financial reporting, executive compensation, and director nominations.
Corporate Governance GuidelinesThe company adheres to corporate governance guidelines based on NYSE standards, including minimum stock ownership requirements for directors and officers.N/APromotes alignment of interests between management and stockholders.
Clawback PolicyThe company has a clawback policy to comply with NYSE listing standards and SEC rules, requiring the repayment of incentive compensation in certain cases of financial restatement.Upon listing of common stock on the NYSEEnhances accountability and reduces the risk of excessive risk-taking.

Related Party Transactions

  • The document discloses indemnification agreements with directors and executive officers.
  • The document discloses Listing Equity Awards granted to directors, executive officers, and employees.
  • The document discloses lock-up agreements with directors and executive officers in connection with the February 2024 and September 2024 Offerings.

Stakeholder Impact

  • The company is committed to ethical business practices and dedicated to establishing a corporate responsibility program that benefits its residents, tenants, operators, employees, communities and investors.
  • The company aims to foster positive relationships and contribute to the well-being of the communities in which it operates.

Next Steps

  • Stockholders are encouraged to vote on the proposals outlined in the proxy statement.
  • The company will hold its 2025 Annual Meeting of Stockholders on June 25, 2025.
  • The company will continue to implement its corporate responsibility program.
  • The company will continue to monitor and manage cybersecurity risks.

Key Dates

DateDescription
2021-01-01Start date for various equity award calculations.
2021-12-31End date for various equity award calculations.
2022-01-01Start date for various equity award calculations.
2022-12-31End date for various equity award calculations.
2023-01-01Start date for various equity award calculations.
2023-12-31End date for various equity award calculations.
2024-01-01Start date for various equity award calculations.
2024-03-25Date of Compensation Committee approval of 2024 short-term incentive program and equity awards.
2024-12-31End date for various equity award calculations and financial reporting.
2025-03-27Record date for the 2025 Annual Meeting of Stockholders.
2025-04-10Date of the proxy statement.
2025-06-24Deadline for proxy submission via mail.
2025-06-24Deadline for proxy submission via internet or telephone (11:59 p.m. Eastern Time).
2025-06-25Date of the 2025 Annual Meeting of Stockholders.
2025-12-11Deadline for stockholder proposals for the 2026 Annual Meeting.
2026-06-25Expected date of the 2026 Annual Meeting of Stockholders.

Keywords

Annual Meeting, Proxy Statement, Board of Directors, Executive Compensation, Healthcare REIT, Deloitte & Touche, Equity Plan, Corporate Governance, Real Estate, Stockholders

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.